|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets: | |||||||||
| Cash | |||||||||
| Prepaid expense | |||||||||
| Total current assets | |||||||||
| Long-term prepaid expenses | |||||||||
| Cash held in Trust Account | |||||||||
| Total assets | |||||||||
| Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit | |||||||||
| Accrued offering costs and expenses | |||||||||
| Promissory note - related party | |||||||||
| Due to related party | |||||||||
| Total current liabilities | |||||||||
| Deferred underwriting commissions | |||||||||
| Total liabilities | |||||||||
| Class A ordinary shares subject to possible redemption, 11,302,534 shares at $11.34 and $11.14 redemption value for March 31, 2024 and December 31, 2023, respectively | |||||||||
| Class A ordinary shares subject to possible redemption | |||||||||
| Total class A ordinary shares subject to possible redemption, 11,302,534 shares at $11.34 and $11.14 redemption value for March 31, 2024 and December 31, 2023, respectively | |||||||||
| Shareholders' Deficit: | |||||||||
| Ordinary shares | |||||||||
| Class A ordinary shares not subject to possible redemption | |||||||||
| Class B ordinary shares | |||||||||
| Accumulated deficit | |||||||||
| Total shareholders' deficit | |||||||||
| Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit |
Loading...
